New incident report
Incident Report Number: 2021-2424
Registrant Reference Number: USA-BAYERBAH-2021-US0009645 (Report 691420)
Registrant Name (Full Legal Name no abbreviations): Elanco
Address: 150 Research Lane, Suite 120
City: Guelph
Prov / State: ON
Country: Canada
Postal Code: N1G 4T2
Domestic Animal
Country: UNITED STATES
Prov / State: NORTH CAROLINA
PMRA Registration No. PMRA Submission No. EPA Registration No. 11556-155
Product Name: Seresto Small Dog
Other (specify)
COLLARYes
Other Units: COLLAR
Site: Animal / Usage sur un animal domestique
Animal's Owner
Dog / Chien
Shih Tzu
1
Male
11
5.897
kg
Skin
>15 min <=2 hrs / >15 min <=2 h
>30 min <=2 hrs / >30 min <=2 h
System
Unknown / Inconnu
No
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
Approximately 2 hours post application, the dog developed emesis and a behavioral disorder NOS. The emesis resolved in approximately 5 minutes. The collar was removed and the dog was evaluated by a veterinarian. No treatment was performed. On approximately 23-Mar-2020, the behavioral disorder resolved. On approximately 01-Jan-2021, the dog was evaluated by a veterinarian and was diagnosed with neoplasm NOS. It is undetermined if treatments were performed. On approximately 01-Feb-2021, the dog died. No further information is expected. This case is closed.
Death
O - Unclassifiable/unassessable Reported behavioural sign and emesis are unspecific and may have numerous other causes but they may occur shortly after product application. Time to onset consistent. Further, diagnosed unspecific neoplasm and death are not expected following appropriate topical product application as inconsistent with products pharmacological profile. Oral exposure to the collar is not expected to cause such signs either. An overdose of 5 collars around the neck was investigated in adult cats and dogs for an 8 months period and in 10-week old kittens and week old puppies for a 6 months period without causing serious signs. This is supported by the extremely low systemic exposure with imidacloprid and flumethrin, particularly during the first week after application and also thereafter. Moreover, serious signs were reported long time after product removal, thus not related to product. Considering the product profile, product involvement is deemed unlikely in this geriatric dog, however due to limited information (e.g: status of health, necropsy details), case is considered unassessable.